Resistance Exercise, Recovery Drinks and Appetite

NCT ID: NCT02764177

Last Updated: 2016-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Whilst the effects of manipulating the macronutrient content of foods on appetite and energy intake has been relatively well studied at rest, little is known about these responses in a post-exercise context. The effect of post-exercise nutrition on recovery from or adaptation to exercise has been well studied. However, many exercisers do so for weight management and thus any post-exercise nutrition might impact on energy balance and might need to be carefully considered. This study will examine the impact of manipulating the composition of a recovery drink consumed after resistance exercise on subsequent appetite and energy intake.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects perform a bout of lower body resistance exercise lasting \~50 min and immediately post-exercise they consume one of two recovery drinks over a 5 min period. Over the next 60 min subjective appetite responses will be measured and then 60 min after drink ingestion, subjects will consume an ad-libitum meal.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Active Population

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Protein

In this arm the subjects were provided with a PROTEIN drink to consume after exercise. This protein drink contained whey protein isolate that provided 0.3 g/ kg body mass of protein.

Group Type EXPERIMENTAL

Protein drink

Intervention Type DIETARY_SUPPLEMENT

The protein drink was administered during this trial

Carbohydrate

In this arm the subjects were provided with a CARBOHYDRATE drink to consume after exercise. This carbohydrate drink was energy matched to the protein drink in the other arm of the experiment.

Group Type EXPERIMENTAL

Carbohydrate drink

Intervention Type DIETARY_SUPPLEMENT

The carbohydrate drink was administered in this trial

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Protein drink

The protein drink was administered during this trial

Intervention Type DIETARY_SUPPLEMENT

Carbohydrate drink

The carbohydrate drink was administered in this trial

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Generally fit and healthy
* Use resistance exercise as part of weekly training
* Weight stable in previous 6 months

Exclusion Criteria

* Smoker
* History of gastric, digestive, cardiovascular or renal disease
* Lactose, dairy, gluten intolerances or allergies
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Loughborough University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lewis James

Dr Lewis James

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R15-P106

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.